Richard Roth

Professional Education

Graduate & Fellowship Program Affiliations

• Cancer Biology
• Chemical and Systems Biology

Web Site Links

• http://molepharm.stanford.edu/faculty/homepages/roth.html

Research Interests

Insulin is one of the primary regulators of rapid anabolic responses in the body. Defects in the synthesis and/or ability of cells to respond to insulin results in the condition known as diabetes mellitus. To better design methods of treatment for this disorder, we have been focusing our research on how insulin elicits its various biological responses. We are utilizing the techniques of immunology, molecular biology, and biochemistry to study:

(i) How does the insulin receptor initiate the response to insulin? Like various oncogenes, the insulin receptor has an intrinsic enzymatic activity; it phosphorylates various proteins on tyrosine residues. This enzymatic activity has been found to be critical for insulin to elicit its various responses. The receptor kinase tyrosine phosphorylates various endogenous proteins. These proteins bind and activate a lipid kinase called a phosphatidylinositol 3-kinase. This kinase activates a serine/threonine kinase called Akt or PKB. A major focus is to understand the role of this serine kinase in eliciting various biological responses. Novel substrates for this kinase are being isolated and genes regulated by this kinase are being identified.

(ii) How is the response to insulin modulated? Cells from non-insulin dependent diabetics (the most common form of diabetes, ~5 million in the US) exhibit a profound resistance to insulin. This resistance can be mimicked in cell cultures by stimulating the serine phosphorylation of the insulin receptor and/or various substrates of the insulin recpetor tyrosine kinase. We are therefore exploring the hypothesis that excessive serine phosphorylation of the insulin receptor and/or insulin receptor substrates in these individuals causes this insulin resistance. We are determining the serine residues phosphorylated in the receptor and insulin receptor substrates, the enzymes response for this phosphorylation, and the consequences of these phosphorylations;

(iii) How is the...

Publications

• Increased workload fully activates the blunted IRS-1/PI3-kinase/Akt signaling pathway in atrophied uremic muscle. Chen Y, Sood S, Biada J, Roth R, Rabkin R. Kidney Int. 2008; 73 (7): 848-55
• Protein kinase B/Akt phosphorylation of PDE3A and its role in mammalian oocyte maturation. Han SJ, Vaccari S, Nedachi T, Andersen CB, Kovacina KS, Roth RA, Conti M. EMBO J. 2006; 25 (24): 5716-25
• On the mechanism for neomycin reversal of wortmannin inhibition of insulin stimulation of glucose uptake. Shimaya A, Kovacina KS, Roth RA. J Biol Chem. 2004; 279 (53): 55277-82
• Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cdelta. Greene MW, Morrice N, Garofalo RS, Roth RA. Biochem J. 2004; 378 (Pt 1): 105-16
• Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation. Greene MW, Sakaue H, Wang L, Alessi DR, Roth RA. J Biol Chem. 2003; 278 (10): 8199-211